Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes-Reference-Cited by-同舟云学术

Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes

Published:2022-04 Issue: Volume:186 Page:109827
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

de Vries Marieke,Westerink Jan,El-Morabit Fatima,Kaasjager H.A.H. (Karin),de Valk Harold W.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat Rev Gastroenterol Hepatol,2013

4. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus;Targher;Nat Rev Endocrinol,2018

5. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis;Younossi;J Hepatol,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetes;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

2. Type 1 diabetes and combined acute and chronic complications are associated with risk of progression of liver fibrosis: a Mendelian randomization study;Frontiers in Endocrinology;2024-08-05

3. Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes;Diabetes, Obesity and Metabolism;2024-06-25

4. Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease;Frontiers in Endocrinology;2024-05-08

5. Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes;European Journal of Endocrinology;2024-04-29